Cannabinoids' Intriguing Impact on Various Cancer Cells: Cannabinoids, Endocannabinoids and Cancer

Cannabinoids, the compounds found in Medical Cannabis, exhibit captivating effects that vary depending on the type of cancer cells. They play a role in restraining cancer cell growth, impeding tumour spread, and stimulating cell death, scientifically known as apoptosis.

Recent research underscores that cannabinoids not only provide relief for certain cancer symptoms but also exhibit the potential to reduce tumour growth in animal studies. They achieve this by influencing crucial cell signalling pathways that control the growth and survival of cancer cells. While these advancements are indeed promising, there remains much to uncover about the endocannabinoid system's role in cancer. This burgeoning field holds promise for targeted cancer treatments and innovative combination therapies.

At the Maxine Rava Foundation, our drive is fueled by the determination to explore and harness the potential of cannabinoids for the betterment of cancer patients, especially here in Australia. Let's together push the boundaries of medical research and open up new avenues in the battle against cancer.

For a more comprehensive understanding, you may delve into the National Library of Medicine's article titled "Cannabinoids, Endocannabinoids and Cancer" by Daniel Hermanson and Lawrence Marnett. In their conclusion, they affirm that "...Cannabinoids exert various intriguing effects dependent on the cell line or tumour type. Synthetic cannabinoids and the endocannabinoid system are implicated in inhibiting cancer cell proliferation and angiogenesis, reducing tumour growth and metastases, and inducing apoptosis."

Click here to read more.

Next
Next

Empowering Cancer Research: Maxine Rava Foundation's Collaboration with Technion and Promising Steps Towards ER-Positive Breast Cancer Therapy